Roles for corticotropin-releasing factor receptor type 1 in energy homeostasis in mice

被引:8
|
作者
Sakamoto, Ryuichi [1 ]
Matsubara, Eri [2 ]
Nomura, Masatoshi [1 ]
Wang, Lixiang [1 ]
Kawahara, Yuta [1 ]
Yanase, Toshihiko [2 ]
Nawata, Hajime [1 ]
Takayanagi, Ryoichi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Fukuoka 8140180, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2013年 / 62卷 / 12期
基金
日本学术振兴会;
关键词
Corticotropin-releasing factor receptor; Diabetes; Glucose homeostasis; Hepatic steatosis; INSULIN; UROCORTIN; BIOLOGY; SYSTEM; THERMOGENESIS; SECRETION; PITUITARY; OBESITY; STRESS;
D O I
10.1016/j.metabol.2013.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Expression of corticotropin-releasing factor type 1 receptor (CRFR1) has been shown on pancreatic beta cells, and its activation potentiates glucose-stimulated insulin secretion (GSIS). However, the roles of CRFR1 in energy metabolism beyond insulin release remain elusive. Materials/Methods. We characterized the metabolic phenotypes of mice lacking CRFR1 (CRFR1KO mice) under conditions of energy excess. Results. When fed a normal diet, the glucose profile of CRFR1KO mice in response to a glucose tolerance test was similar to that of wild-type (WT) mice, while serum insulin levels were significantly lower in CRFR1KO mice, reflecting high insulin sensitivity in part due to very low glucocorticoid levels. Histology of the pancreas revealed islet hypoplasia in CRFR1KO mice, suggesting a role of CRFR1 in maintaining the beta cell mass in a manner similar to incretins. In response to a high-fat diet, CRFR1KO mice showed insulin resistance, but serum insulin levels during glucose challenge remained at a low level, indicating defective GSIS. In addition, CRFR1KO mice showed resistance to diet-induced obesity and hepatic steatosis. Although total food intake was not different between CRFR1KO and WT mice, oxygen consumption was significantly increased in CRFR1KO mice. The increased energy expenditure may explain the lean phenotype of CRFR1KO mice under conditions of energy excess. Conclusions. Our results suggest that CAPRI plays important roles in whole body energy homeostasis, providing compelling evidence of the close relationship between energy homeostasis and the function of the hypothalamic-pituitary-adrenal axis. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1739 / 1748
页数:10
相关论文
共 50 条
  • [1] Corticotropin-Releasing Factor Acting on Corticotropin-Releasing Factor Receptor Type 1 is Critical for Binge Alcohol Drinking in Mice
    Kaur, Simranjit
    Li, Ju
    Stenzel-Poore, Mary P.
    Ryabinin, Andrey E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (02) : 369 - 376
  • [2] Corticotropin-releasing factor receptor type 1 colocalizes with type 2 in corticotropin-releasing factor-containing cellular profiles in rat brain
    Fan, Jun-Ming
    Chen, Xue-Qun
    Wang, Xi
    Hao, Ke
    Du, Ji-Zeng
    NEUROENDOCRINOLOGY LETTERS, 2014, 35 (05) : 417 - 426
  • [3] Type 1 Corticotropin-Releasing Factor Receptor Expression Reported in BAC Transgenic Mice: Implications for Reconciling Ligand-Receptor Mismatch in the Central Corticotropin-Releasing Factor System
    Justice, Nicholas J.
    Yuan, Zung Fan
    Sawchenko, Paul E.
    Vale, Wylie
    JOURNAL OF COMPARATIVE NEUROLOGY, 2008, 511 (04) : 479 - 496
  • [4] Corticotropin-releasing factor 1 receptor antagonists: a patent review
    Williams, John P.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 1057 - 1068
  • [5] Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis
    Carlin, KM
    Vale, WW
    Bale, TL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3462 - 3467
  • [6] Corticotropin-releasing factor receptor antagonists
    Gilligan, Paul J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (07) : 913 - 924
  • [7] Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding
    Kraetke, O
    Wiesner, B
    Eichhorst, J
    Furkert, J
    Bienert, M
    Beyermann, M
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2005, 25 (4-6) : 251 - 276
  • [8] Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs
    White, Melvin R.
    Graziano, Michael J.
    Sanderson, Thomas P.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (02) : 110 - 120
  • [9] A sexually dimorphic distribution of corticotropin-releasing factor receptor 1 in the paraventricular hypothalamus
    Rosinger, Zachary J.
    Jacobskind, Jason S.
    De Guzman, Rose M.
    Justice, Nicholas J.
    Zuloaga, Damian G.
    NEUROSCIENCE, 2019, 409 : 195 - 203
  • [10] Corticotropin-Releasing Hormone Receptor Antagonists: An Update
    Zoumakis, E.
    Chrousos, G. P.
    PEDIATRIC NEUROENDOCRINOLOGY, 2010, 17 : 36 - 43